Search Results

Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan

Author: Salti, I.

Source: Diabetic Medicine, Volume 26, Number 12, December 2009 , pp. 1255-1261(7)

Publisher: Blackwell Publishing

Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents

Authors: Wolffenbuttel, B. H. R.; Klaff, L. J.; Bhushan, R.; Fahrbach, J. L.; Jiang, H.; Martin, S.

Source: Diabetic Medicine, Volume 26, Number 11, November 2009 , pp. 1147-1155(9)

Publisher: Blackwell Publishing

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

Authors: Davies, M. J.; Donnelly, R.; Barnett, A. H.; Jones, S.; Nicolay, C.; Kilcoyne, A.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1153-1162(10)

Publisher: Blackwell Publishing

A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine

Authors: Misurski, Derek; Lage, Maureen J.; Fabunmi, Rosalind; Boye, Kristina S.

Source: Applied Health Economics and Health Policy, Volume 7, Number 4, 1 December 2009 , pp. 245-254(10)

Publisher: Adis International

Insulin glargine dually compared

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 12-12(1)

Publisher: Adis International

EASD studies shed light on costs of insulin initiation for T2DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 3-4(2)

Publisher: Adis International

Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes

Authors: Hompesch, Marcus; Ocheltree, Scott M.; Wondmagegnehu, Eshetu T.; Morrow, Linda A.; Kollmeier, Alexa P.; Campaigne, Barbara N.; Jacober, Scott J.

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2679-2687(9)

Publisher: Informa Healthcare

Stellenwert von Langzeit-Insulin-Analoga in der Therapie des Diabetes mellitus Typ 2

Authors: Ludvik, Bernhard; Brath, Helmut; Wascher, Thomas; Toplak, Hermann

Source: Wiener klinische Wochenschrift, Volume 121, Numbers 13-14, July 2009 , pp. 473-482(10)

Publisher: Springer

Insulin glargine trumps insulin detemir in Germany

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 6-6(1)

Publisher: Adis International

Long-acting insulin detemir was not associated with an increased cancer risk

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 3-3(1)

Publisher: Adis International

Where now for insulin glargine - a time for pragmatic medicine?

Authors: Thomson, G. A.; Craig, R.

Source: International Journal of Clinical Practice, Volume 63, Number 10, October 2009 , pp. 1413-1415(3)

Publisher: Blackwell Publishing

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

Authors: Arutchelvam, V.; Heise, T.; Dellweg, S.; Elbroend, B.; Minns, I.; Home, P. D.

Source: Diabetic Medicine, Volume 26, Number 10, October 2009 , pp. 1027-1032(6)

Publisher: Blackwell Publishing

Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting

Authors: Mittendorf, T.; Smith-Palmer, J.; Timlin, L.; Happich, M.; Goodall, G.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 11, November 2009 , pp. 1068-1079(12)

Publisher: Blackwell Publishing

Evidence linking Lantus to higher cancer risk inconclusive − Medsafe

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 3-3(1)

Publisher: Adis International

Exenatide trumps insulin glargine in cost effectiveness

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 1-1(1)

Publisher: Adis International

Liraglutide: A Review of its Use in Type 2 Diabetes Mellitus

Authors: Croom, Katherine F.; McCormack, Paul L.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1985-2004(20)

Publisher: Adis International

Future Therapeutic Directions: New Medications and Insulin Delivery in a Changing World for Effective Diabetes Management

Author: Modi, Pankaj

Source: Current Drug Discovery Technologies, Volume 6, Number 3, September 2009 , pp. 200-213(14)

Publisher: Bentham Science Publishers

Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus

Authors: Kawamori, R.; Kadowaki, T.; Ishii, H.; Iwasaki, M.; Iwamoto, Y.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 9, September 2009 , pp. 891-899(9)

Publisher: Blackwell Publishing

Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE™ observational study

Authors: Kurtoglu, Selim; Atabek, Mehmet Emre; Dizdarer, Ceyhun; Pirgon, Ozgur; Isguven, Pinar; Emek, Sevil

Source: Pediatric Diabetes, Volume 10, Number 6, September 2009 , pp. 401-407(7)

Publisher: Blackwell Publishing

Available data do not provide a cause for concern regarding insulin glargine and the risk of cancer

Source: Reactions, Volume 1, Number 1263, 2009-08-01 , pp. 2-2(1)

Publisher: Adis International